In conclusion, we have identified a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein, characterised by TRAIL-induced one-way pro-apoptotic crosstalk between the TRAIL receptor signaling pathway and TrkAIII, in SH-SY5Y NB cells. The gene discussed is TNFSF10; the disease is neuroblastoma.